# Paul N. Durrington

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-n-durrington/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,600 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 84 |
| i10-index | 258 |
| Last Known Institution | University of Manchester |
| OpenAlex ID | https://openalex.org/A5086859309 |
| ORCID iD | https://orcid.org/0000-0001-9561-7887 |
| Works | 430 |

## Researcher papers

- [Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial](https://scholariq.org/papers/primary-prevention-of-cardiovascular-disease-with-atorvastatin-in-type-2/)
- [European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-4/)
- [ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias-the-task-force-for-the/)
- [Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins](https://scholariq.org/papers/association-of-ldl-cholesterol-non-hdl-cholesterol-and-apolipoprotein-b-levels/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias/)
- [Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins](https://scholariq.org/papers/paraoxonase-biochemistry-genetics-and-relationship-to-plasma-lipoproteins/)
- [Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function](https://scholariq.org/papers/effects-of-high-dose-modified-release-nicotinic-acid-on-atherosclerosis-and/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Paraoxonase enzyme and polymorphisms](https://scholariq.org/topics/paraoxonase-enzyme-and-polymorphisms/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Lipid metabolism and disorders](https://scholariq.org/topics/lipid-metabolism-and-disorders/)

## Researcher university

- [University of Manchester](https://scholariq.org/institutions/university-of-manchester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.